Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 20, 2017 - Issue 1
274
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of concurrent administration of mifepristone and misoprostol for termination of pregnancy

, , , &
Pages 43-47 | Received 25 Aug 2015, Accepted 26 Jan 2016, Published online: 02 Nov 2016

References

  • Ashok, P.W., Templeton, A., Wagaarachchi, P.T., & Flett, G.M. (2002). Factors affecting the outcome of early medical abortion: A review of 4132 consecutive cases. BJOG, 109, 1281–1289. doi: 10.1016/S1470-0328(02)02956-7.
  • Chaudhuri, P., Mandal, A., Das, C., & Mazumdar, A. (2014). Dosing interval of 24 hours versus 48 hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy. International Journal of Gynaecology and Obstetrics, 124, 134–138. doi: 10.1016/j.ijgo.2013.08.009.
  • Chawdhary, R., Rana, A., & Pradhan, N. (2009). Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: A quasi-randomized controlled trial. The Journal of Obstetrics and Gynaecology Research, 35, 78–85. doi: 10.1111/j.1447-0756.2008.00864.x.
  • Couzinet, B., Le Strat, N., Ulmann, A., Baulieu, E.E., & Schaison, G. (1986). Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone). The New England Journal of Medicine, 315, 1565–1570. doi:10.1056/NEJM198612183152501.
  • Coyaji, K., Elul, B., Krishna, U., Otiv, S., Ambardekar, S., Bopardikar, A., … Winikoff, B. (2001). Mifepristone abortion outside the urban research hospital setting in India. Lancet, 357, 120–122. doi:10.1016/S0140-6736(00)03549-2.
  • Creinin, M.D., Fox, M.C., Teal, S., Chen, A., Schaff, E.A., & Meyn, L.A. (2004). A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstetrics and Gynecology, 103, 851–859. doi: 10.1097/01.AOG.0000124271.23499.84.
  • Creinin, M.D., Schreiber, C.A., Bednarek, P., Lintu, H., Wagner, M.S., & Meyn, L.A. (2007). Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: A randomized controlled trial. Obstetrics and Gynecology, 109, 885–894. doi: 10.1097/01.AOG.0000258298.35143.d2.
  • El-Refaey, H., Rajasekar, D., Abdalla, M., Calder, L., & Templeton, A. (1995). Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. The New England Journal of Medicine, 332, 983–987. doi: 10.1056/NEJM199504133321502.
  • Fox, M.C., Creinin, M.D., & Harwood, B. (2002). Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation. Contraception, 66, 225–229. doi: 10.1016/S0010-7824(02)00358-X.
  • Guest, J., Chien, P.F., Thomson, M.A., & Kosseim, M.L. (2007). Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG, 114, 207–215. doi:10.1111/j.1471-0528.2006.01179.x.
  • Heikinheimo, O., Suhonen, S., & Haukkamaa, M. (2004). One- and 2-day mifepristone–misoprostol intervals are both effective in medical termination of second-trimester pregnancy. Reproductive Biomedicine Online, 8, 236–239. doi:10.1016/S1472-6483(10)60522-6.
  • Li, Y.T., Chen, F.M., Chen, T.H., Li, S.C., Chen, M.L., & Kuo, T.C. (2006). Concurrent use of mifepristone and misoprostol for early medical abortion. The Taiwanese Journal of Obstetrics and Gynecology, 45, 325–328. doi:10.1016/S1028-4559(09)60252-7.
  • Marions, L. (2006). Mifepristone dose in the regimen with misoprostol for medical abortion. Contraception, 74, 21–25. doi: 10.1016/j.contraception.2006.03.017.
  • Murthy, A.S., Creinin, M.D., Harwood, B., & Schreiber, C. (2005). A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. Contraception, 71, 333–336. doi:10.1016/j.contraception.2004.10.006.
  • Shi, Y.E., Ye, Z.H., He, C.H., Zhang, G.Q., Xu, J.Q., Van Look, P.F., & Fotherby, K. (1993). Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women. Contraception, 48, 133–149. doi:10.1016/0010-7824(93)90004-Q.
  • Spitz, I.M., Bardin, C.W., Benton, L., & Robbins, A. (1998). Early pregnancy termination with mifepristone and misoprostol in the United States. The New England Journal of Medicine, 338, 1241–1247. doi: 10.1056/NEJM199804303381801.
  • Swahn, M.L., Wang, G., Aedo, A.R., Cekan, S.Z., & Bygdeman, M. (1986). Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women. Contraception, 34, 469–481. doi:10.1016/0010-7824(86)90056-9.
  • Ventura, S.J., Curtin, S.C., Abma, J.C., & Henshaw, S.K. (2012). Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990–2008. National Vital Statistics Reports, 60, 1–21. http://www.ncbi.nlm.nih.gov/pubmed/22970648.
  • Winikoff, B., Sivin, I., Coyaji, K.J., Cabezas, E., Xiao, B., Gu, S., … Ellertson, C. (1997). Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone–misoprostol versus surgical abortion. American Journal of Obstetrics and Gynecology, 176, 431–437. doi: 10.1016/S0002-9378(97)70511-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.